Youth use and appeal of e-cigarettes and intervention development Suchitra Krishnan-Sarin, Ph.D. Professor of Psychiatry, Yale University School of Medicine Co-PI, Yale Tobacco Center of Regulatory Sciences
Youth use and appeal of e-cigarettes and intervention development
Suchitra Krishnan-Sarin, Ph.D.Professor of Psychiatry, Yale University School of Medicine
Co-PI, Yale Tobacco Center of Regulatory Sciences
FDA Regulation of tobacco products
Family Smoking Prevention and Tobacco Control Act
The FSPTCA became law on June 22, 2009. It gives the Food and Drug Administration (FDA) the authority to regulate the manufacture, distribution, and marketing of tobacco products to protect public health.
E-cigarettes emerge….• First smokeless cigar invented in 1963• In 2003, Hon Lik, a Chinese pharmacist patented modern e-
Cigarette design. The company Lik worked for, Golden Dragon Holdings, developed the device and changed its name to Ruyan, which means “like smoke.”
• Today, there are over 400 e-Cigarette Brands.• E-cigarettes started appearing in the US market 2006-2009
•Smoking Everywhere files a federal complaint. Smoking Everywhere contends that the FDA has no authority over electronic cigarettes, as they are a “tobacco product,” and the FDA’s attempt to regulate them infringes on Congress’s intent to withhold FDA jurisdiction over tobacco products. Smoking Everywhere contends that electronic cigarettes are not “drugs,” “drug delivery systems,” or “drug device combinations” under 21 U.S.C 321(g).
FDA adds electronic cigarettes to Import Alert 66-41 and directs the U.S. Customs and Border Protection to reject the entry of electronic cigarettes into the United States on the basis of them being unapproved drug delivery devices.
March 2009
April 2009
Are they a tobacco product or a drug delivery device???
Smoking Everywhere v. FDA, U.S. Court of Appeals in Washington rules the FDA can only regulate e-cigarettes as a tobacco product, unless therapeutic claims are made.
December 2010
US District Court (district of Columbia) prohibits the FDA from seizing e-cigarettes as drug or drug/device combinations.Jan
2010
FDA shall not detain or refuse admission into the United States of NJOY's electronic cigarette products on the ground that those products are unapproved drugs, devices, or drug-device combinations under the FDCA, absent a proffer of evidence, consistent with the Court's Memorandum Opinion, that NJOY's products are intended to have a therapeutic effect;
E-cigarettes can only be regulated as tobacco products
Per FSPTCA, E-cigarettes contain nicotine from tobacco and can only be regulated as tobacco
products
BUTThe FSPTCA did not cover e-cigarettes till 2016
THEREFOREFrom 2010 to Oct 2016
E-cigarettes were not regulated
E-cigarette Evolution
Cigarette “like”Disposable (non refillable, non re-chargeable) CartridgeRefillable
Non cigarette “like”Water pipe CigarTank (active and passive delivery) ModifiedPod systems
New Design FeaturesDual coil Change Voltage Control puff duration
E-cigarettes!!
Battery-operated devices used to inhale an aerosol, which may contain nicotine, flavorings, and other chemicals.
The Present
Heat –not-butn
Other JUUL-like productsPhix, Suorin
Sales of e-Cigarettes
• Sales projected to be 27.7 billion by 2022• Source: Wells Fargo
Sales dollar of e-cigarettes in Nielsen-tracked retail channels: by brand 2011–2017.
Jidong Huang et al. Tob Control doi:10.1136/tobaccocontrol-2018-054382
©2018 by BMJ Publishing Group Ltd
Population Based
Surveys
Web-based cross-sectional survey
Retail SalesData
0%
10%
20%
30%
40%
50%
60%
70%
80%
2013 2014 2015 2016 2017 2018
Perc
ent o
f Tot
al E
-cig
aret
te D
olla
r Sa
les
YearAltria British American Tobacco Imperial Tobacco Japan Tobacco JUUL Labs… Other
2019
E-Cigarette Market Share, by Dollar Sales, US, 2013 - 2018
Source: King, Brian A, The Rise of the Pod Mod: Trends in E-Cigarette Sales in the US, 2013-2017. Paper presented at: 25th Annual Meeting of SRNT; February 2019; San Francisco, CA.
E-Cigarettes Make Aerosol, Not Vapor
What draws youth to e-cigarettes?
Connecticut focus groups and surveys
Longitudinal surveys and focus groups (2014-onwards)4-6 high schools in Southeastern CT
Dfferent CT District Reference Groups
E-cigarette use reasons among youth users Wave 1 (Fall 2013) Surveys in CT
0
10
20
30
40
50
60
70
Perc
enta
ge
MiddleSchool(n=41)
High School(n=912)
Kong et al. (2014) NTR
Multiple Innovative devices!!
E-cigarette Evolution
Cigarette “like”Disposable (non refillable, non re-chargeable) CartridgeRefillable
Non cigarette “like”Water pipe CigarTank (active and passive delivery) ModifiedPod systems
New Design FeaturesWattage ControlPuff control
Appeal of customizable product features among susceptible non-users and current users
(2015)26
.5
12.9
6.7
5.2
2.0 3.4
10.8
3.7
73.4
3.1
23.0
9.9
5.5
5.2
3.7
2.9
10.2
3.1
49.3
1.8
55.9
36.9
21.5
22.3
16.0
10.8
19.7
9.9 15
.9
5.8
0
10
20
30
40
50
60
70
80
90
100
Perc
ent
Susceptible, Tobacco-Naive Never-Users Susceptible, Tobacco-Exposed Never-usersCurrent E-cigarette Users
Camenga et al. (2018) TRS
Youth are using different devices (2017)
25.4
60.664.2
71.2
7.3
18.7
47.1
33.1
0
10
20
30
40
50
60
70
80
90
100
CIG-A-LIKE VAPE/HOOKAH PEN JUUL MODS
Perc
ent
Ever Current
Krishnan-Sarin et al. (2019) DAD
Youth are using multiple devices (2017)
VAPE/HOOKAH PEN + JUUL + MODS24%
JUUL + MODS20%
All17%
VAPE/HOOKAH PEN + MODS
16%
DISP + VAPE/HOOKAH PEN + MODS8%
VAPE/HOOKAH PEN + JUUL7%
DISP + VAPE/HOOKAH PEN2.6%
DISP + VAPE/HOOKAH PEN + JUUL2.6%
DISP + JUUL + MODS1.6% DISP + JUUL
0.8%
DISP + MODS0.8%
Krishnan-Sarin et al. (2019) DAD
Over 15000 Flavors!!
> 15,000 flavorsFlavors Made up of multiple chemicals with known toxicity profiles
(inflammation, free radical generation, oxidative stress…)
BenzaldehydeCinnamaldehydeAcroleinFurfuralDiacetylβ-damascone,δtetradecalactoneγ-decalactonecitraldipenteneethyl maltolethyl vanillin ethyl vanillin PG acetallinalool piperonal DipenteneETC….
Flavorants and toxicityVanillinAcetoinDiacetylPentanedioneCinnamaldehydeFurfural (chocolate)Maltol (cotton candy)CoumarinBenzaldehyde (fruity flavors, esp. cherry)
(Allen et al., 2016; Tierney et al., 2016; Muthumalage et al., 2018)
Cytotoxicity of Flavor chemicals
Flavorants and toxicity
Erythropel HC, Jabba SV, De Winter TM, Mendizabal M, Anastas PT, Jordt SE, Zimmerman JB. Nicotine & Tobacco Research 2018. DOI: 10.1093/ntr/nty192
Flavors used by Youth in E-cigarettes (2017)
Flavors used by Youth vs Adults in E-cigarettes (2017)
Morean ME, Butler ER, Bold KW, Kong G, Camenga DR, et al. (2018) Preferring more e-cigarette flavors is associated with e-cigarette use frequency among adolescents but not adults. PLOS ONE 13(1): e0189015. https://doi.org/10.1371/journal.pone.0189015https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189015
Table 2. Predictors of e-cigarette use frequency in adults and adolescents.
Morean ME, Butler ER, Bold KW, Kong G, Camenga DR, et al. (2018) Preferring more e-cigarette flavors is associated with e-cigarette use frequency among adolescents but not adults. PLOS ONE 13(1): e0189015. https://doi.org/10.1371/journal.pone.0189015https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189015
Total flavors preferred predict e-cigarette use frequency in youth but not in adults
Flavorants in Electronic Cigarettes
Pharmacological effects Modulate somatosensory responses and nicotine
irritancy perception
Affect nicotine intake
Menthol (High dose) reduces Sensory Irritant Responses from Nicotine (High dose)
• Human Sensory Testing Paradigm
• E-cigarette vapor exposure in young adult users
Rosbrook and Green, Nicotine Tob Res, 2016
Menthol improves the taste of E-liquids
• Human E-cigarette Exposure Paradigm
• E-cig puff exposure in young adult e-cig users
Krishnan-Sarin et al., Drug and Alcohol Dependence, in press
0
5
10
15
20
25
30
No Menthol Low Menthol High Menthol
Disli
ke/L
ike
Tast
e of
E-c
igar
ette
s (-
100
to 1
00)
Like Taste of E-cigarettes(Menthol main effect, p<0.001)
Menthol increases liking for E-liquids with nicotine
• Human E-cigarette Exposure Paradigm
• E-cig puff exposure in young adult e-cig users-20
-10
0
10
20
30
40
50
No Menthol Low Menthol High Menthol
Disli
ke/L
ike
Tast
e of
E-c
ig (-
100
to
100)Like Taste of E-cigarettes
(Menthol*Nicotine, p<0.05)
0 mg Nicotine 6 mg/ml Nicotine 12 mg/ml Nicotine
p<0.05
Krishnan-Sarin et al., Drug and Alcohol Dependence, in press
“Youth believe ads for flavored e-liquids target individuals about their age, not older adults”
McKelvey et al., 2019
Flavor Ads activate Brain Reward PathwaysGarrison et al., 2017
+
Ratings/restSweet/fruit e-cigor menthol cig
Tobacco e-cigor regular cig
Ratings/rest
How much do you like this product?
1 2 3 4
How likely is it that youwill try this product in the future?
+
How much do you like this product?
1 2 3 4
How likely is it that youwill try this product in the future?
WARNING
WARNING
Post-scan memory task
Control images
Eye tracking
Have you seen this message before?
Do Flavor Ads activate Brain Reward Pathways?Garrison et al., 2017
Flavor ads activate brain reward circuitrysweet/fruit v. tobacco stimuli
NAc
Con
trast
Val
ue
Control Sweet/fruit Tobacco-1.1
-0.6
-0.1
0.4
0.9
* *
* p<.05
Garrison et al., 2018
Do Flavor ads change attention paid to E-cig warning labels on risks of nicotine and toxic
chemicals?
• Content taken from U.S. gov. websites (FDA, CDC, NIH) and www.thetruth.com
• E-cig warnings concerned potential risks of nicotine and chemical constituents
NAc
con
trast
val
ue
Warning label memory score
NAc response correlated with memory for warning labels
Greater activation of brain reward circuitry is related to poorer memory for warnings
r=-.43, p=.03
Nicotine and Addiction!!
Nicotine concentration Used by Youth (2015)
Camenga et al. (2018) TRS
Do youth use nicotine in their ecigs? (2017)
Krishnan-Sarin et al. (2019)
Nicotine delivery can be changed by device power
Adapted from Wagener TL, Floyd EL, Stepanov I, Driskill LM, Frank SG, Meier E, Leavens EL, Tackett AP, Molina N, Queimado L. Tob Control. 2017 Mar;26(e1):e23-e28. doi: 10.1136/tobaccocontrol-2016-053041. Epub 2016 Oct 11.
Third GenerationN = 11�̅�𝑥 = 71.6 W�̅�𝑥 = 4.1 mg/ml
Second GenerationN = 9�̅�𝑥 = 8.6 W�̅�𝑥 = 22.3 mg/ml
Pre Post0
5
10
15
20
25
*
Third Gen.Second Gen.
Plasma Nicotine Concentration (N = 20)
Time relative to 10 puffs
ng/
ml
Benzoic Acid
00Nicotine Salts
Free Base
Nicotine
Nicotine delivery can be changed by use of nicotine salts
Reasons for Liking JUUl among youth current e-cigarette users (2018)
Kong et al., 2020
Reasons for Disliking JUUL among youth current e-cigarette users (2018)
Kong et al., 2020
Reasons for Liking JUULs and frequency of JUUL use among current e-cig users
Unadjusted Models Adjusted ModelB (SE) β B (SE) β
Reasons for likingPharmacological effects 22.87 (1.67) 0.42 9.49 (1.59) 0.17Product characteristics 13.81 (1.18) 0.36 3.47 (1.24) 0.09Peer influences -3.59 (0.79) -0.15 -2.43 (0.61) -0.10Comparative perceptions to other e-cigs 6.91 (1.45) 0.16 -1.14 (1.20) -0.03Ability to hide 9.37 (1.04) 0.29 1.26 (0.97) 0.04“Other” reason for liking 3.67 (2.16) 0.06 2.86 (1.56) 0.04
Demographic Sex (Ref. = Female) 1.12 (0.75) 0.05 -0.78 (0.58) -0.03Race (Ref. = Non-White) 1.43 (0.87) 0.06 1.85 (0.66) 0.07Age 1.67 (0.30) 0.18 0.43 (0.24) 0.05
JUUL use characteristics Use my own JUUL 13.78 (0.63) 0.58 9.27 (0.64) 0.39
Past-30-day use of other tobacco products 9.39 (0.69) 0.40 3.49 (0.65) 0.15Past-30-day use of other e-cigarette devices 9.11 (0.75) 0.37 4.38 (0.66) 0.18
Kong et al., 2020
Nicotine is highly addictive and the adolescent brain is sensitive to even low levels of nicotine
• Adolescent animals get more easily addicted to nicotine than adults
• Most human cigarette smoking starts prior to the age of 18
• Smokers who start prior to the age of 18 have greater chronic disease burden and find it harder to quit smoking
Nicotine is a neurotoxin in the adolescent brain
In adolescent animals nicotine is a well established neurotoxin• Pruning and brain development• Changes neural pathways and behaviors related to
learning, memory, attention processes • Leads to hyperactivity. • Makes it easier to get addicted to other substances
• produces epigenetic changes (genes involves in asthma and depression)
Adolescent humans who smoke also experience memory and attention deficits after using cigarettes, and have greater rates of depression and anxiety
Nicotine has an effect on almost all processes in the human body
Alternative Use Behaviors!!
Dripping/Vape Tricks
In June 2017, 0f 1047 high school e-cigarette ever users, 35.7% had tried vape tricks
In June 2017, 0f 1047 high school e-cigarette ever users, 22.5% had tried dripping
Dripping/Vape Tricks (2017)Past 30 day rates among e-cigarette users
26.1%
14.9%
18.6%20.0%
27.0%
20.2%18.8%
21.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
0 days 1-3 days 4-14 days 15-30 days
Days of Dripping among Adolescents Who Tried Dripping (N=215)
Days of Vape Tricks Conducted among Adolescents Who Tried Vape Tricks (N=575)
Vape Cannabis
Morean et al., (2015) Pediatrics
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
Total Samplen = 3,847
All Lifetime E-cigarette users
n = 1,075
Lifetime DualUsers (E-
cigarettes andCannabis)
n = 724
Vaporizing Cannabis using E-cigarettes
2014
What can we do to reduce youth e-cig use?
• Product regulation• Reduce or limit flavors?• Reduce nicotine concentrations?• Include nicotine content labels that are easy to understand• Remove youth appealing packaging ( e.g. flavors)?• Create efficient devices that cannot be manipulated• Dealing with marijuana vaping?
• Other regulatory efforts that have shown benefit for reducing cigarette smoking• Restricting youth sales and access• Restricting advertising• Taxation
What can we do to reduce youth e-cig use?
• Education and Prevention• Teachers, parents, children• Change harm perceptions about Nicotine • Change harm perceptions about Flavors.
• Cessation• Develop interventions based on behavioral and pharmacological
methods that have worked for cigarette smoking• Understand ecigarette cues• Understand e-cigarette and nicotine dependence and withdrawal
• Develop interventions for marijuana vaping
Treatment Modalities used with Youth
• 5 A’s (USDHHS, 2012)• Cognitive Behavioral Therapy
• Goal setting, self-monitoring, cognitive reframing, problem solving, coping skills• Motivational Interviews or Enhancement
• Addressing resistance with confrontation, strengthening desire to quit, reducing ambivalence about quitting, supporting self-efficacy
• Behavior Change based on Transtheoretical Model of Change• Identifying stage (precontemplation, contemplation, preparation, action, maintenance)
and facilitating behavior change using ME• Pharmacological Interventions
Nicotine patch and inhaler, bupropion, varenicline • Novel Interventions
• Behavioral Reinforcement (Contingency Management, Quit and win)• Approach Avoidance Training (Habitual approach tendencies)• Behavioral Activation Training (for smokers with Depression)
Treatment settings
• Schools/Colleges• Ideal setting to access youth• Confidentiality problems in schools
• Health Care Settings• Great Teaching moment when with Pediatrician/Primary care doc• Lack of provider time • Lack of Follow up
• Internet and mobile phones• Great reach• Lower efficacy• Hard to keep youth motivated and engaged